Company: BDRX
Filing Date: 2025-06-27
Form Type: 424B3
Source: 0001214659-25-009733
Chunk: 4

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-06-27
Form: 424B3
Chunk 4
---
a shall
file from time to time or announcements that may be made by Biodexa in accordance with the rules and regulations promulgated by the SEC,
which contain and identify other important factors that could cause actual results to differ materially from those contained in any projections
or forward-looking statements. These forward-looking statements speak only as of the date of this announcement. All subsequent written
and oral forward-looking statements by or concerning Biodexa are expressly qualified in their entirety by the cautionary statements above.
Except as may be required under relevant laws in the United States, Biodexa does not undertake any obligation to publicly update or revise
any forward-looking statements because of new information, future events or events otherwise arising.